Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Colony-stimulating factor-1 receptor (CSF-1R), or FMS kinase, is a transmembrane protein crucial for myeloid cell function.
• CSF-1R signaling pathways (PI3K-AKT, JAK-STATs, MAPKs) regulate immune cell proliferation, differentiation, migration, and activation.
• Dysregulated CSF-1R activity is implicated in tumor immune evasion and various inflammatory conditions.

Purpose of the Study:

• To review the complex roles of CSF-1R and its ligands in innate immunity.
• To highlight the therapeutic potential of inhibiting CSF-1R signaling in inflammatory diseases.
• To discuss the controversies surrounding CSF-1R's pathological mechanisms and biomarker potential in inflammation.

Main Methods:

• Literature review of preclinical and clinical studies on CSF-1R signaling.
• Analysis of the molecular pathways regulated by CSF-1R activation.
• Examination of therapeutic strategies targeting CSF-1R in cancer and inflammation.

Main Results:

• CSF-1R inhibition can deplete and reprogram tumor-associated macrophages, reducing immune suppression.
• Excessive CSF-1R activation contributes to inflammation in multiple organs.
• Agents targeting CSF-1R are under investigation for treating inflammatory diseases.

Conclusions:

• CSF-1R signaling has multifaceted roles in innate immune responses.
• Blocking CSF-1R offers a promising therapeutic avenue for cancer and inflammatory diseases.
• Further research is needed to elucidate CSF-1R's pathological mechanisms in inflammation and its biomarker utility.